Literature DB >> 19754405

Cognitive impairment and dementia in patients with Parkinson disease.

James B Leverenz1, Joseph F Quinn, Cyrus Zabetian, Jing Zhang, Kathleen S Montine, Thomas J Montine.   

Abstract

Parkinson disease (PD) is an already prevalent neurodegenerative disease that is poised to at least double over the next 25 years. Although best known for its characteristic movement disorder, PD is now appreciated commonly to cause cognitive impairment, including dementia, and behavioral changes. Dementia in patients with PD is consequential and has been associated with reduced quality of life, shortened survival, and increased caregiver distress. Here we review clinical presentation and progression, pathological bases, identification of genetic risk factors, development of small molecule biomarkers, and emerging treatments for cognitive impairment in patients with PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754405      PMCID: PMC2804995     

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  157 in total

Review 1.  Dementia with Lewy bodies.

Authors:  James B Leverenz; Ian G McKeith
Journal:  Med Clin North Am       Date:  2002-05       Impact factor: 5.456

2.  Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease.

Authors:  L Verhagen Metman; P Del Dotto; P van den Munckhof; J Fang; M M Mouradian; T N Chase
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  Mental symptoms in Parkinson's disease are important contributors to caregiver distress.

Authors:  D Aarsland; J P Larsen; K Karlsen; N G Lim; E Tandberg
Journal:  Int J Geriatr Psychiatry       Date:  1999-10       Impact factor: 3.485

Review 5.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

Review 6.  The natural history of Parkinson's disease.

Authors:  W H Poewe; G K Wenning
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

7.  Clinicopathological study of 35 cases of multiple system atrophy.

Authors:  G K Wenning; Y Ben-Shlomo; M Magalhães; S E Daniel; N P Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

8.  Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

Authors:  Alan L Whone; Ray L Watts; A Jon Stoessl; Margaret Davis; Sven Reske; Claude Nahmias; Anthony E Lang; Olivier Rascol; Maria J Ribeiro; Philippe Remy; Werner H Poewe; Robert A Hauser; David J Brooks
Journal:  Ann Neurol       Date:  2003-07       Impact factor: 10.422

9.  Clinical and neuropathological findings in Lewy body dementias.

Authors:  D Galasko; R Katzman; D P Salmon; L Hansen
Journal:  Brain Cogn       Date:  1996-07       Impact factor: 2.310

10.  Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism.

Authors:  F J Vingerhoets; B J Snow; C S Lee; M Schulzer; E Mak; D B Calne
Journal:  Ann Neurol       Date:  1994-11       Impact factor: 10.422

View more
  31 in total

Review 1.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

2.  Contributions of striatal dopamine signaling to the modulation of cognitive flexibility.

Authors:  Martin Darvas; Richard D Palmiter
Journal:  Biol Psychiatry       Date:  2010-11-11       Impact factor: 13.382

3.  Acute exposure to the mitochondrial complex I toxin rotenone impairs synaptic long-term potentiation in rat hippocampal slices.

Authors:  Ryoichi Kimura; Lu-Yao Ma; Chen Wu; Dharshaun Turner; Jian-Xin Shen; Kevin Ellsworth; Makoto Wakui; Marwan Maalouf; Jie Wu
Journal:  CNS Neurosci Ther       Date:  2012-05-22       Impact factor: 5.243

Review 4.  Gut Microbiota Disorder, Gut Epithelial and Blood-Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways.

Authors:  Menizibeya O Welcome
Journal:  Neuromolecular Med       Date:  2019-05-21       Impact factor: 3.843

Review 5.  Imaging approaches for dementia.

Authors:  A D Murray
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-01       Impact factor: 3.825

6.  Relative contributions of severe dopaminergic neuron ablation and dopamine depletion to cognitive impairment.

Authors:  R Garrett Morgan; Jeffrey T Gibbs; Erica J Melief; Nadia O Postupna; Emily E Sherfield; Angela Wilson; C Dirk Keene; Thomas J Montine; Richard D Palmiter; Martin Darvas
Journal:  Exp Neurol       Date:  2015-06-14       Impact factor: 5.330

Review 7.  Loss of gait control assessed by cognitive-motor dual-tasks: pros and cons in detecting people at risk of developing Alzheimer's and Parkinson's diseases.

Authors:  Maroua Belghali; Nathalie Chastan; Fabien Cignetti; Damien Davenne; Leslie M Decker
Journal:  Geroscience       Date:  2017-05-27       Impact factor: 7.713

8.  Plasma apolipoprotein A1 as a biomarker for Parkinson disease.

Authors:  Judy K Qiang; Yvette C Wong; Andrew Siderowf; Howard I Hurtig; Sharon X Xie; Virginia M-Y Lee; John Q Trojanowski; Dora Yearout; James B Leverenz; Thomas J Montine; Matt Stern; Susan Mendick; Danna Jennings; Cyrus Zabetian; Ken Marek; Alice S Chen-Plotkin
Journal:  Ann Neurol       Date:  2013-08-06       Impact factor: 10.422

9.  Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease.

Authors:  Martin Darvas; Charles W Henschen; Richard D Palmiter
Journal:  Neurobiol Dis       Date:  2014-02-01       Impact factor: 5.996

Review 10.  What can imaging tell us about cognitive impairment and dementia?

Authors:  Leela Narayanan; Alison Dorothy Murray
Journal:  World J Radiol       Date:  2016-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.